Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: a randomized, double-blind, parallel-group, multicenter study.
Baerwald C, Verdecchia P, Duquesroix B, Frayssinet H, Ferreira T. Baerwald C, et al. Among authors: duquesroix b. Arthritis Rheum. 2010 Dec;62(12):3635-44. doi: 10.1002/art.27694. Arthritis Rheum. 2010. PMID: 20722026 Free article. Clinical Trial.
Blood pressure effects of naproxcinod in hypertensive patients.
Townsend R, Bittar N, Rosen J, Smith W, Ramsay A, Chrysant SG, Weiss R, Pivodic A, Duquesroix B, Djian J. Townsend R, et al. Among authors: duquesroix b. J Clin Hypertens (Greenwich). 2011 May;13(5):376-84. doi: 10.1111/j.1751-7176.2010.00419.x. Epub 2011 Jan 25. J Clin Hypertens (Greenwich). 2011. PMID: 21545399 Free PMC article. Clinical Trial.
Effects of naproxcinod on blood pressure in patients with osteoarthritis.
White WB, Schnitzer TJ, Bakris GL, Frayssinet H, Duquesroix B, Weber M. White WB, et al. Among authors: duquesroix b. Am J Cardiol. 2011 May 1;107(9):1338-45. doi: 10.1016/j.amjcard.2010.12.046. Epub 2011 Mar 2. Am J Cardiol. 2011. PMID: 21371681 Clinical Trial.
A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dolomites Study.
Walters TR, Kothe AC, Boyer JL, Usner DW, Lopez K, Duquesroix B, Fechtner RD, Navratil T. Walters TR, et al. Among authors: duquesroix b. J Glaucoma. 2022 Jun 1;31(6):382-391. doi: 10.1097/IJG.0000000000002030. Epub 2022 Apr 6. J Glaucoma. 2022. PMID: 35394456 Free PMC article. Clinical Trial.